RVL Pharmaceuticals plc

RVLP | NASDAQ | 0 Obserwujący

$0.03

-32.05%

-$0.01

Obserwuj

Overview Metrics Financials

Company Quality

Profitability Score

17/100

Solvency Score

28/100

Dividends

Dividends data currently unavailable.

Earnings

Earnings data currently unavailable.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sektor

Biotechnology

Branża

Mr. Brian A. Markison

Prezes

125

Pracownicy

Bridgewater

Siedziba główna

Kraj

Key Metrics TTM

Valuation

Market cap.

$3.1M

Enterprise Value

$16M

Price to Earnings

-0.05

Price to Sales

0.06

Price to Book

0.05

Price to Cash Flow

-0.08

Profitability

Return on Assets

-40.22%

Return on Equity

-80.88%

Return on Invested Capital

-41.26%

Gross Margin

80.98%

Operating Margin

-91.87%

Net Margin

-103.96%

Liquidity

Quick Ratio

2.85

Current Ratio

2.89

Cash Ratio

2.26

Inventory Turnover

12.06

Asset Turnover

0.39

Total Liabilities

$69M

Solvency

Debt to Assets

0.45

Debt to Equity

N/A

Interest Coverage

-14.69

Equity Ratio

0.19

Long-term Debt to Cap.

0.52

Altman Z-Score

-11.50

Performance

Performance data currently unavailable.

Earnings Waterfall

Debt level and coverage

Debt level and coverage data currently unavailable.

Earnings

Feed

There are no posts to show right now.